From DCAT Value Chain Insights (VCI)
Salix Pharmaceuticals, Ltd., a specialty pharmaceutical company, reports that Carolyn Logan will retire as president and chief executive officer (CEO), and as a director, of the company, effective January 30, 2015. Ms. Logan will remain a consultant to the company.
Tom D’Alonzo, currently chairman of Salix’s board of directors. will be appointed acting CEO, effective January 30, 2015, and William Bertrand, Jr., the company’s senior vice president and general counsel, will be appointed acting chief operating officer, pending the company’s hiring of a permanent CEO.
Source: Salix Pharmaceuticals
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription